Contact effects by mitochondria: biological destruction of cultivated B16 - F10 melanoma cells
Автор: Kit Oleg I., Frantsiyants Elena M., Filippova Svetlana Y., Neskubina Irina V., Mezhevova Irina V., Shikhlyarova Alla I., Kaplieva Irina V., Trepitaki Lidia K., Pogorelova Yulia A., Gusareva Marina A., Bykadorova Oksana V., Serdyukova Elizaveta V., Khokhlova Olga V., Kuchkina Lyudmila P., Gurnak Viktor V., Surikova Ekaterina I.
Журнал: Cardiometry @cardiometry
Статья в выпуске: 24, 2022 года.
Бесплатный доступ
In recent years therapeutic effects produced by mitochondria, transplanted to pathogenic regions in an organism, which demonstrate their high migration activity and tropicity with respect to filling of energetic vacuum, have been inspiring a renewed interest in the scientific community. In this context, this raises the question of the source of metabolically active mitochondria and their histological compatibility required for the mitochondrial transplantation. Aim. The aim of our research work is to study characteristics/ quality of mitochondria from cells of the liver and the heart in rats, which in the in vitro system have produced their impact on different biological features of the B16-F10 murine melanoma cell culture. Materials and methods. In our research work we have used cells of the B16-F10 murine melanoma cell line culture. In the framework of the study, an experiment with mitochondria harvested from the liver and the heart of a rat has been conducted. Mitochondria have been isolated using differential centrifugation with a high-speed refrigerated centrifuge. With the B16-F10 culture cells, we have designed the following variants of our experiments: 1) use of cardiac mitochondria (1 mg/mL, in terms of total protein); 2) use of cardiac mitochondria (1 mg/mL) + succinic acid (10-4%); 3) mitochondria of the liver (1 mg/mL, in terms of total protein); 4) use of mitochondria of the liver (1 mg/mL) + succinic acid (10-4%); 5) use of succinic acid (10-4%) solely; 6) the reference specimen with no use of mitochondria and the above agents. An assessment of the impact made by mitochondria on the migration of the B16-F10 cells has been performed with the scratch wound healing test. For the purpose of an analysis of the effect produced by mitochondria on the energetic metabolism of the B16-F10 cell culture we have measured main parameters of the cell respiration and glycolysis in stress tests with adding some toxic chemicals. The rate of the cellular respiration has been assessed by measuring the amount of oxygen taken in (oxygen consumption rate, OCR), and the glycolysis level has been evaluated by the extracellular acidification rate (ECAR). Results. Adding cardiac and hepatic mitochondria to the cultivated B16-F10 cells has produced a pronounced cytopathic effect, which has become more remarkable upon expiration of two days of the cell cultivation and which has consisted in cytoplasm granulation and partial detaching of the cells. Introducing mitochondria of the heart to the cultivated B16-F10 cells has induced a considerable decrease both in the background-related and the maximum level of oxygen consumption by the B16-F10 cells as against the reference samples without adding of mitochondria. Adding the cardiac mitochondria has led to a statistically significant decrease in the base level of ECAR by 14,36 mpH/min (t = 3,12, df = 10) as compared with the reference values. Introducing hepatic mitochondria has also resulted in a reduction of the average value of ECAR as against the background by 4,8 mpH/min. Conclusion. Metabolically active mitochondria are capable of reformatting energetic fluxes in tumor cells and change their cellular respiration that leads to the most effectively realized death of the cultivated B16-F10 tumor cells.
Mitochondria, b16-f10 cell culture, oxygen consumption rate, extracellular acidification rate, cytotoxic effect
Короткий адрес: https://sciup.org/148326576
IDR: 148326576 | DOI: 10.18137/cardiometry.2022.24.106114
Список литературы Contact effects by mitochondria: biological destruction of cultivated B16 - F10 melanoma cells
- Spees JL, Olson SD, Whitney MJ, Prockop DJ. Mitochondrial Transfer between Cells Can Rescue Aerobic Respiration. Proceedings of the National Academy of Sciences of the United States of America. 2006;103:1283-1288. doi:10.1073/pnas.0510511103.
- Nascimento-Dos-Santos G., de-Souza-Ferreira E., Linden R., Galina A., Petrs-Silva H. Mitotherapy: unraveling a promising treatment for disorders of the central nervous system and other systemic conditions. Cells. 2021;10(7):1827. doi:10.3390/cells10071827.
- Berridge MV, Dong LF, Neuzil J. Mitochondrial DNA in tumor initiation, progression and metastasis: role of horizontal mtDNA transfer. Cancer Res. 2015; 75: 3203-3208.
- Fu A, et al. Healthy mitochondria inhibit the metastatic melanoma in lungs. Int. J. Biol. Sci. 2019;15:2707–2718. doi: 10.7150/ijbs.38104.
- Kit OI, et al. Mitochondrial therapy of melanoma B16/F10, pathophysiological parameters of tumor regression. Cardiometry. 2022; 22:56-61. doi: 10.18137/cardiometry.2022.22.5661.
- Kit OI, et al. Biological effects of mitochondrial therapy: preventing development of myocardial infarction and blocking metastatic aggression of B16/ F10 melanoma. Cardiometry. 2022; 22:50-55. doi: 10.18137/cardiometry.2022.22.5055.
- Frantsiyants EM, et al. Content of apoptosis factors and self-organization processes in the mitochondria of heart cells in female mice C57BL/6 under growth of melanoma B16/F10 linked with comorbid pathology. Cardiometry. 2021:18:121-130. doi: 10.18137/cardiometry.2021.18.121130.
- Kit OI, et al. Mitochondrial therapy: direct visual assessment of the possibility of preventing myocardial infarction under chronic neurogenic pain and B16 melanoma growth in the experiment. Cardiometry. 2022; 22:38-49. doi: 10.18137/cardiometry. 2022.22.3849.
- Frantsiyants EM, et al. The functional state of mitochondria of cardiomyocytes in a malignant process against the background of comorbid pathology in the experiment. South Russian Journal of Oncology. 2021;2(3):13-22. doi: 10.37748/2686-9039-2021-2-3-2.[in Russian]
- Nascimento-Dos-Santos G., et al. Neuroprotection from optic nerve injury and modulation of oxidative metabolism by transplantation of active mitochondria to the retina. Biochim. Biophys. Acta Mol. Basis Dis. 2020;1866:165686. doi: 10.1016/j.bbadis.2020.165686.
- Nakamura Y, Park JH, Hayakawa K. Therapeutic use of extracellular mitochondria in CNS injury and disease. Exp. Neurol. 2020;324:113114.doi: 10.1016/j.expneurol.2019.113114.
- Doulamis I.P., Guariento A., Duignan T., Orfany A., Kido T., Zurakowski D., Del Nido P.J., McCully J.D. Mitochondrial transplantation for myocardial protection in diabetic hearts. Eur. J. Cardio-Thoracic Surg. 2020;57:836–845. doi: 10.1093/ejcts/ezz326.
- Clark MA, Shay JW. Mitochondrial transformation of mammalian cells. Nature. 1982;295:605–607.doi: 10.1038/295605a0.
- Chang JC, et al. Allogeneic/xenogeneic transplantation of peptide-labeled mitochondria in Parkinson’s disease: Restoration of mitochondria functions and attenuation of 6-hydroxydopamine–induced neurotoxicity. Transl. Res. 2016;170:40–56. doi: 10.1016/j.trsl.2015.12.003.
- Ramirez-Barbieri G, et al. Alloreactivity and allorecognition of syngeneic and allogeneic mitochondria. Mitochondrion. 2019; 46: 103-115. doi: 10.1016/j.mito.2018.03.002.
- Egorova MV, Afanasiev SA. Isolation of mitochondria from cells and tissues of animals and humans: Modern methodological techniques. Siberian Medical Journal. 2011; 26(1-1): 22-28.
- Béatrice Morioa, Baptiste Panthua, Arthur Bassot, Jennifer Rieusset. Role of mitochondria in liver metabolic health and diseases. Cell Calcium. 2021; 94: 102336. https://doi.org/10.1016/j.ceca.2020.102336.
- Jungermann K. Metabolic zonation of liver parenchyma. Semin. Liver Dis., 8 (1988), pp. 329-341, 10.1055/s-2008-1040554.
- Matsumoto S, et al. Investigation of the hepatic respiration and liver zonation on rat hepatocytes using an integrated oxygen biosensor in a microscale device. Biotechnol. Prog. 2019; 35: e2854, 10.1002/btpr.2854.
- Jaakko L. Pohjoismäki, Steffi Goffart. The role of mitochondria in cardiac development and protection. Free Radical Biology and Medicine. 2017; 106:345-354. https://doi.org/10.1016/j.freeradbiomed.2017.02.032.
- Rong Tian, et al. Unlocking the Secrets of Mitochondria in the Cardiovascular System: Path to a Cure in Heart Failure. Circulation. 2019 Oct 1; 140(14): 1205–1216. doi: 10.1161/CIRCULATIONAHA. 119.040551.
- Shirakabe А., Y. Ikeda, S. Sciarretta, D.K. Zablocki, J. Sadoshima Aging and autophagy in the heart. Circ. Res. 2016; 118 (10): 1563-1576.
- Chen Y., Liu Y., Dorn G.W. Mitochondrial fusion is essential for organelle function and cardiac homeostasis. Circ. Res. 2011;109 (12): 1327-1331.
- Wai J., et al. Imbalanced OPA1 processing and mitochondrial fragmentation cause heart failure in mice. Science. 2015; 350 (6265): aad0116.
- Lopaschuk G.D., Ussher J.R., Folmes C.D., Jaswal J.S., Stanley W.C. Myocardial fatty acid metabolism in health and disease. Physiol. Rev. 2010; 90 (1): 207-258.
- Forner F., Foster LJ., Campanaro S., Valle G., Mann M. Quantitative proteomic comparison of rat mitochondria from muscle, heart, and liver. Mol Cell Proteomics. 2006;5(4):608-19. doi: 10.1074/mcp.M500298-MCP200.